Get the Stockscreener App
4.405
0.23%
-0.015
Adaptive Biotechnologies Corp Stock (ADPT) Forecast
The Adaptive Biotechnologies Corp (ADPT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $11.60, representing a +163.41% increase from the current price of $4.405. The highest analyst price target is $11.03, and the lowest is $12.18.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ADPT Price Target
Average 10.21
(+131.84% Upside)
Is Adaptive Biotechnologies Corp (ADPT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 37.77 | Neutral |
| STOCH(9,6) | 7.0352 | Buy |
| STOCHRSI(14) | 26.36 | Neutral |
| MACD(12,26) | -0.0668 | Sell |
| ADX(14) | 28.08 | Sell |
| William %R | -97.93 | Buy |
| CCI(14) | -132.77 | Sell |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.267
Sell
|
4.9458
Sell
|
| MA20 |
5.1965
Sell
|
5.0728
Sell
|
| MA50 |
4.9606
Sell
|
4.9453
Sell
|
| MA100 |
4.6459
Sell
|
4.6663
Sell
|
| MA200 |
3.9942
Buy
|
4.5697
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, ADPT could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on ADPT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 37.77 indicates that ADPT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 7.0352 indicates that ADPT is oversold. This indicates that ADPT price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 26.36 indicates that ADPT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 28.08 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -132.77 indicates that ADPT is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term ADPT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Adaptive Biotechnologies Corp financial reports and earnings history, Adaptive Biotechnologies Corp (ADPT) stock could reach $42.64 by 2030, $21.05 by 2040 and $77.43 by 2050. See the projected annual prices until 2050 of the Adaptive Biotechnologies Corp stock below:
- Adaptive Biotechnologies Corp (ADPT) is expected to reach an average price of $5.5912 in 2035, with a high prediction of $6.2539 and a low estimate of $5.9062. This indicates an $26.93% rise from the last recorded price of $4.405.
- Adaptive Biotechnologies Corp (ADPT) stock is projected to chart a bullish course in 2040, with an average price target of $19.45, representing an $341.64% surge from its current level. The forecast ranges from a conservative $19.54 to a sky-high $21.05.
- Our analysts predict Adaptive Biotechnologies Corp (ADPT) to jump 856.36% by 2045, soaring from $42.89 to an average price of $42.13, potentially reaching $43.18. While $42.89 is the low estimate, the potential upside is significant.
- Adaptive Biotechnologies Corp (ADPT) stock is expected to climb by 2050, reaching an average of $76.15, a $1,629% jump from its current level. However, a wide range of estimates exists, with high and low targets of $77.43 and $76.57, respectively, highlighting the market's uncertainty.
Adaptive Biotechnologies Corp Stock (ADPT) Year by Year Forecast
Adaptive Biotechnologies Corp Stock (ADPT) Price Forecast for 2024
Our forecast for ADPT stock price in 2024 now indicates an average price target of $7.7791 with a high forecast of $15.29 and a low forecast of $0.2665. The average prediction reflects an increase of +76.60% from the last recorded price of $4.405.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $12.32 | $12.18 | $11.03 | +179.73% |
Adaptive Biotechnologies Corp Stock (ADPT) Price Forecast for 2025
Adaptive Biotechnologies Corp Stock (ADPT) is expected to reach an average price of $12.34 in 2025, with a high prediction of $24.67 and a low estimate of $0.00118. This indicates an +180.03% rise from the last recorded price of $4.405.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $5.4624 | $9.0424 | $9.43 | +24.00% |
| February, 2025 | $16.91 | $12.58 | $14.23 | +283.99% |
| March, 2025 | $12.87 | $13.26 | $12.35 | +192.10% |
| April, 2025 | $1.85 | $7.4644 | $9.4876 | -58.00% |
| May, 2025 | $1.4376 | $0.4218 | $4.7482 | -67.36% |
| June, 2025 | $11.59 | $1.4071 | $11.74 | +163.00% |
| July, 2025 | $1.2714 | $0.3571 | $12.60 | -71.14% |
| August, 2025 | $5.46 | $0.2312 | $8.65 | +23.95% |
| September, 2025 | $11.60 | $0.00118 | $13.61 | +163.28% |
| October, 2025 | $17.68 | $9.9271 | $20.19 | +301.47% |
| November, 2025 | $16.31 | $11.31 | $20.42 | +270.31% |
| December, 2025 | $23.39 | $11.04 | $24.67 | +430.97% |
Adaptive Biotechnologies Corp Stock (ADPT) Price Forecast for 2026
The predicted value for Adaptive Biotechnologies Corp (ADPT) in 2026 is set at an average of $20.34. Estimates vary from a peak of $39.49 to a trough of $1.1859, indicating an +361.65% surge from the present price of $4.405.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $28.22 | $22.24 | $33.33 | +540.57% |
| February, 2026 | $29.89 | $22.69 | $39.49 | +578.65% |
| March, 2026 | $11.36 | $7.3823 | $36.02 | +157.94% |
| April, 2026 | $10.65 | $5.27 | $16.55 | +141.76% |
| May, 2026 | $12.08 | $9.3282 | $15.45 | +174.17% |
| June, 2026 | $8.8847 | $1.1859 | $12.61 | +101.70% |
| July, 2026 | $12.68 | $6.3841 | $15.22 | +187.89% |
| August, 2026 | $11.15 | $6.27 | $13.38 | +153.11% |
| September, 2026 | $8.2565 | $2.7521 | $11.21 | +87.43% |
| October, 2026 | $13.51 | $8.4359 | $13.61 | +206.79% |
| November, 2026 | $7.0518 | $6.0818 | $13.53 | +60.09% |
| December, 2026 | $8.3188 | $5.8212 | $12.66 | +88.85% |
Adaptive Biotechnologies Corp Stock (ADPT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Adaptive Biotechnologies Corp (ADPT) is $6.1365, with a high forecast of $12.14 and a low forecast of $0.1341. This indicates an +39.31% increase from the last price of $4.405.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.0665 | $0.1665 | $9.0782 | -75.79% |
| February, 2027 | $4.3641 | $0.1341 | $6.6647 | -0.93% |
| March, 2027 | $5.5088 | $1.3265 | $6.4782 | +25.06% |
| April, 2027 | $8.0912 | $7.1194 | $7.9712 | +83.68% |
| May, 2027 | $8.9435 | $8.2718 | $8.8334 | +103.03% |
| June, 2027 | $10.19 | $7.3453 | $8.0815 | +131.25% |
| July, 2027 | $12.17 | $11.78 | $12.14 | +176.25% |
| August, 2027 | $12.87 | $12.40 | $11.81 | +192.19% |
| September, 2027 | $10.64 | $10.93 | $11.83 | +141.64% |
| October, 2027 | $9.3065 | $9.7653 | $9.0515 | +111.27% |
| November, 2027 | $7.3888 | $7.2577 | $6.5588 | +67.74% |
| December, 2027 | $10.62 | $9.11 | $9.3118 | +141.13% |
Adaptive Biotechnologies Corp Stock (ADPT) Price Forecast for 2028
In 2028, Adaptive Biotechnologies Corp (ADPT) is projected to reach an average price of $5.5374, with a high projection of $9.5435 and a low estimate of $1.5312. This indicates an +25.71% rise from the last price of $4.405.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $10.05 | $10.03 | $9.5435 | +128.24% |
| February, 2028 | $6.5865 | $8.5459 | $8.6247 | +49.52% |
| March, 2028 | $6.9294 | $7.0988 | $7.2277 | +57.31% |
| April, 2028 | $6.2318 | $7.0818 | $7.0712 | +41.47% |
| May, 2028 | $3.9847 | $4.9747 | $4.6041 | -9.54% |
| June, 2028 | $4.6871 | $5.0671 | $4.5771 | +6.40% |
| July, 2028 | $4.2094 | $4.9744 | $4.1594 | -4.44% |
| August, 2028 | $4.7524 | $4.0306 | $3.54 | +7.89% |
| September, 2028 | $4.3847 | $5.1547 | $4.8541 | -0.46% |
| October, 2028 | $2.3071 | $3.4071 | $4.0303 | -47.63% |
| November, 2028 | $1.87 | $2.9144 | $3.4792 | -57.55% |
| December, 2028 | $3.0524 | $1.5312 | $2.5574 | -30.71% |
Adaptive Biotechnologies Corp Stock (ADPT) Price Forecast for 2029
The 2029 price forecast for Adaptive Biotechnologies Corp Stock (ADPT) is $25.57 on average, with a high prediction of $50.91 and a low estimate of $0.2183. This represents an +480.38% increase from the previous price of $4.405.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.6053 | $2.0297 | $2.648 | -40.86% |
| February, 2029 | $3.3077 | $2.4509 | $2.5677 | -24.91% |
| March, 2029 | $2.97 | $3.335 | $3.1088 | -32.58% |
| April, 2029 | $2.4424 | $2.7524 | $2.4518 | -44.55% |
| May, 2029 | $1.1153 | $1.3703 | $1.943 | -74.68% |
| June, 2029 | $1.3477 | $1.0659 | $0.9577 | -69.41% |
| July, 2029 | $1.09 | $1.3982 | $1.2344 | -75.26% |
| August, 2029 | $0.473 | $0.2824 | $0.495 | -89.26% |
| September, 2029 | $0.9453 | $0.7141 | $0.3397 | -78.54% |
| October, 2029 | $0.2827 | $0.2183 | $0.3471 | -93.58% |
| November, 2029 | $51.59 | $52.97 | $50.91 | +1,071% |
| December, 2029 | $47.35 | $51.67 | $49.62 | +974.87% |
Adaptive Biotechnologies Corp Stock (ADPT) Price Forecast for 2030
Adaptive Biotechnologies Corp Stock (ADPT) is expected to reach an average price of $43.42 in 2030, with a high forecast of $57.81 and a low forecast of $29.03. This signifies an +885.73% surge from the last price of $4.405.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $44.77 | $44.13 | $42.64 | +916.44% |
| February, 2030 | $54.81 | $48.61 | $55.06 | +1,144% |
| March, 2030 | $59.32 | $58.21 | $57.81 | +1,247% |
| April, 2030 | $55.19 | $56.49 | $55.92 | +1,153% |
| May, 2030 | $53.12 | $53.52 | $53.49 | +1,106% |
| June, 2030 | $52.90 | $52.91 | $52.06 | +1,101% |
| July, 2030 | $45.29 | $48.87 | $49.86 | +928.26% |
| August, 2030 | $56.15 | $52.27 | $53.47 | +1,175% |
| September, 2030 | $51.50 | $52.04 | $51.43 | +1,069% |
| October, 2030 | $39.74 | $45.35 | $47.98 | +802.16% |
| November, 2030 | $35.85 | $36.33 | $36.03 | +713.95% |
| December, 2030 | $25.11 | $29.03 | $29.85 | +470.02% |
0.42%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):